Revised RTA confirmation filing for Q1 FY27 dematerialisation
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Emcure Pharmaceuticals has submitted a revised confirmation certificate under SEBI Regulation 74(5) for the quarter ended June 30, 2026. The earlier intimation dated July 07, 2026 had an incorrect enclosure attached inadvertently. The revised certificate from RTA MUFG Intime India confirms that securities received from depository participants for demat during the quarter were accepted or rejected, listed on stock exchanges, and the physical certificates were mutilated and cancelled after verification, with the depository name substituted as registered owner within prescribed timelines.
Routine procedural compliance filing with no material impact on shareholders or stock price. Simply corrects a prior filing that had the wrong enclosure.